|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA07100007
|
methyl-2R-hydroxy-goshuyic acid
|
methyl 2R-hydroxy-5Z,8Z-tetradecadienoate
|
SFE 15:2;O
|
C15H26O3
|
254.188195
|
|
LMFA07100007
|
methyl-2R-hydroxy-goshuyic acid
|
methyl 2R-hydroxy-5Z,8Z-tetradecadienoate
|
SFE 15:2;O
|
C15H26O3
|
254.188195
|
|
LMFA01140109
|
Tripmycin A
|
13-(2-methylphenyl)-12E-tridecenoic acid
|
FA 20:5
|
C20H30O2
|
302.224581
|
|
LMFA01140110
|
|
5-(2-Methylphenyl)-4-pentenoic acid
|
FA 12:5
|
C12H14O2
|
190.099380
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA01050603
|
20-HEPE
|
20-hydroxy-(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid
|
FA 20:5;O
|
C20H30O3
|
318.219496
|
|
LMFA01050604
|
22-HDHA
|
22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
|
LMFA07070133
|
3S-hydroxyoctanoylcarnitine
|
3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 8:0;O
|
C15H29NO5
|
303.204574
|
|
LMFA07070133
|
3S-hydroxyoctanoylcarnitine
|
3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 8:0;O
|
C15H29NO5
|
303.204574
|
|
LMFA07070132
|
3S-hydroxydecanoylcarnitine
|
3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 10:0;O
|
C17H33NO5
|
331.235874
|
|
LMFA07070132
|
3S-hydroxydecanoylcarnitine
|
3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 10:0;O
|
C17H33NO5
|
331.235874
|
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
|
LMFA02000412
|
13S-HOME(9Z)
|
13S-hydroxy-9Z-octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250796
|
|
LMFA02000412
|
13S-HOME(9Z)
|
13S-hydroxy-9Z-octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250796
|
|
LMFA02000413
|
10,13-Dihydroxystearic acid
|
10,13-Dihydroxyoctadecanoic acid
|
FA 18:0;O2
|
C18H36O4
|
316.261361
|
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4
|
320.198761
|